Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
VE-303 by Vedanta Biosciences for Hepatic Encephalopathy: Likelihood of Approval
VE-303 is under clinical development by Vedanta Biosciences and currently in Phase II for Hepatic Encephalopathy. According to GlobalData, Phase...
Data Insights
VE-303 by Vedanta Biosciences for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
VE-303 is under clinical development by Vedanta Biosciences and currently in Phase III for Clostridioides difficile Infections (Clostridium difficile Associated...